PHARMING GROUP revenue breakdown overview

PHARMING GROUP revenue for the last year amounted to 287.09 M EUR, the most of which — 274.76 M EUR — came from its highest performing source at the moment, Recombinant Human C1 Esterase Inhibitor, the year earlier bringing 226.91 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought PHARMING GROUP 265.46 M EUR, and the year before that — 221.17 M EUR.